Beckman wins further five-year deal with VA (US Veterans' Administration):
This article was originally published in Clinica
Executive Summary
Beckman Coulter has signed a five-year purchase contract with the US Veterans' Administration for in vitro diagnostics devices, service and consumables worth a claimed $100 million to the company. This is a renewal of a similar contract and Jeff McHugh, Beckman's field operations director, North America, said the fact that Beckman successfully supplied 100% of routine laboratory blood testing and 75% of specialty tests over that period helped secure the deal.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches
UK switch specialist Maxwellia delivers two “me too” reclassifications in the area of women's health: Evana Heavy Period Relief and Ultravana Period Pain Relief.
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.